Zephyr Sleep Technologies

Calgary, Alberta, Canada  All Canada companies → Founded 2010
Medical Device / Hardware Specialty-Focused AI Wearables / RPM
Dentistry Pulmonology Sleep Medicine
Neurology AI Wearables & Remote Monitoring (RPM)
Formerly VC-backed (last known stage before cessation was Later Stage VC / Series A in 2021) — $16M (total raised prior to cessation of operations)

Products

MATRx plus
Zephyr Sleep Technologies
Neurology AI
MATRx plus was an FDA-cleared, AI-powered at-home medical device for diagnosing obstructive sleep apnea (OSA) and determining optimal oral appliance therapy positions.

See all 1 product →

About Zephyr Sleep Technologies

Zephyr Sleep Technologies was a healthcare AI company that developed FDA-approved, cloud-connected medical devices for the diagnosis and treatment of sleep-disordered breathing, primarily obstructive sleep apnea (OSA). Their flagship product, MATRx plus, was an at-home Class II medical device designed to perform both a standard home sleep test (HST) and an oral appliance trial.

The MATRx plus system leveraged proprietary algorithms, artificial intelligence, and machine learning to identify patients who would be suitable for oral appliance therapy and to recommend an optimal mandibular position for treatment. This technology aimed to reduce the high failure rates historically associated with oral appliance therapy for OSA. The device offered real-time, cloud connectivity, enabling seamless collaboration among dental professionals, sleep physicians, and Zephyr’s servers for comprehensive patient management.

Unfortunately, Zephyr Sleep Technologies ceased operations on June 25, 2021. The company cited the significant impact of the COVID-19 pandemic on the dental services and products industry, coupled with unsuccessful efforts to raise additional equity capital, as the reasons for its closure.

Focus Areas

Diagnosis and treatment of obstructive sleep apnea (OSA) medical devices for sleep-disordered breathing AI and machine learning for oral appliance therapy home sleep testing and patient selection for oral appliances

What Physicians Need to Know

Diagnosis & Treatment of OSA
Zephyr Sleep Technologies specialized in the diagnosis and treatment of Obstructive Sleep Apnea (OSA) through their innovative MATRx plus device. This device was designed to perform both a standard home sleep test (HST) and an oral appliance trial, aiming to identify suitable candidates for oral appliance therapy and determine the optimal therapeutic position.
Medical Devices for Sleep-Disordered Breathing
Their flagship product, MATRx plus, was an FDA-cleared Class II medical device. It was the first-ever at-home device to identify OSA patients suitable for oral appliance therapy. The device was tablet-based, user-friendly, and included instructional videos for self-administration at home.
AI & Machine Learning for Oral Appliance Therapy
Zephyr utilized proprietary algorithms, artificial intelligence (AI), and machine learning to analyze sleep study data. This technology was crucial in predicting whether a patient would respond to oral appliance therapy and in determining the precise mandibular protrusion required for effective treatment, significantly reducing treatment failure rates.
Home Sleep Testing & Patient Selection
The MATRx plus enabled comprehensive home sleep testing and played a vital role in patient selection for oral appliances. It provided medical professionals with data to confidently prescribe an alternative therapy to CPAP, offering a more efficient and patient-friendly approach to OSA treatment.
Key Differentiators
Zephyr's primary differentiator was its ability to predict, with high accuracy (97% positive predictive value), if a patient would respond to oral appliance therapy and to identify the optimal therapeutic mandibular position (86% accuracy). This eliminated much of the guesswork previously associated with oral appliance treatment, leading to faster and more effective therapy. The real-time, cloud-connected system facilitated instant collaboration among health professionals.
Technology Stack
The core technology involved proprietary algorithms, artificial intelligence, and machine learning for data analysis and predictive modeling. The MATRx plus device featured a tablet-based design with instructional videos and offered real-time, cloud connectivity for data sharing and collaboration.
Physician Tip

It is important for physicians to be aware that Zephyr Sleep Technologies ceased operations on June 25, 2021, due to the impact of the COVID-19 pandemic and unsuccessful efforts to secure additional funding. While their MATRx plus system offered innovative solutions for OSA diagnosis and oral appliance therapy planning, the company is no longer operational. Therefore, new prescriptions or reliance on their services for ongoing patient management are not possible. Physicians who previously utilized Zephyr's technology may need to explore alternative solutions for patient selection and oral appliance titration.

Prior to its closure, Zephyr Sleep Technologies had partnered with Dentsply Sirona to integrate the MATRx plus into a 'Simple Sleep Solution,' combining 3D imaging, SICAT Air software, and OPTISLEEP appliances for a comprehensive 3D solution for OSA analysis and treatment. This partnership aimed to create a digital workflow for dental practitioners. However, given Zephyr's cessation of operations, the direct integration and support for the MATRx plus system are no longer available. Any existing integrations would be legacy and not actively supported by Zephyr.

Products by Zephyr Sleep Technologies

1 product in the directory

MATRx plus
Zephyr Sleep Technologies
Neurology AI
MATRx plus was an FDA-cleared, AI-powered at-home medical device for diagnosing obstructive sleep apnea (OSA) and determining optimal oral appliance therapy positions.

What the Web Says

Zephyr Sleep Technologies was a company that developed medical devices for diagnosing and treating sleep-disordered breathing, notably the MATRx and MATRx plus systems. The company ceased operations on June 25, 2021, due to the impact of the COVID-19 pandemic on the dental services and products industry and an inability to raise additional equity capital. Prior to its closure, employee reviews indicated a generally positive workplace culture, though some concerns about management and job security were raised. Product reviews for their MATRx plus device highlighted its innovative technology for identifying suitable candidates for oral appliance therapy and simplifying the treatment process for dental professionals.

Overall: Negative

Strengths

  • Cutting-edge technology for sleep apnea diagnosis and treatment
  • MATRx plus simplifies workflow for dental professionals
  • MATRx plus offers real-time cloud connectivity for collaboration among health professionals
  • Positive workplace culture and respectful environment (prior to closure)
  • Flexible work environment (prior to closure)
  • Product was considered unique in its capabilities

Limitations

  • Company ceased operations in June 2021
  • Poor leadership team cited by some employees (prior to closure)
  • Low job security and advancement opportunities (prior to closure)
  • Product price was a barrier for some (prior to closure)
  • Some employees hoped to never hear of the company again (prior to closure)
  • Management paid on unknown criteria, not performance or merit (prior to closure)

Based on reviews from: Indeed.com, Sleep Review, Capterra, Reddit, G2

Last updated: 2026-07-19

Videos

News, demos, and interviews about Zephyr Sleep Technologies.

Loading videos...

Videos load interactively. If none appear, search YouTube for Zephyr Sleep Technologies →

View all on YouTube

Press & Coverage

Sleep Review
Zephyr Sleep Technologies Ceases Operations
Zephyr Sleep Technologies, known for its MATRx system, ceased operations on June 25, 2021, due to the material impact of the COVID-19 pandemic on the dental services and products industry and unsuccessful efforts to raise additional equity capital.
2021-07
24-7PressRelease.com
Zephyr Sleep to Close. Sleep Group Solutions Committed to Supporting Dental Sleep Practices
Following Zephyr Sleep Technologies' announcement to cease operations, Sleep Group Solutions offered a trade-in program for MATRx users, providing credit towards a new Eccovision Acoustic Pharyngometer/Rhinometer package.
2021-06
Dental Sleep Practice
Zephyr announces co-marketing partnership with ProSomnus
Zephyr Sleep Technologies partnered with ProSomnus Sleep Technologies in a co-marketing agreement, allowing ProSomnus to sell Zephyr's MATRx plusu2122 and Zephyr to market ProSomnus sleep and snore devices.
2020-02
SleepArchiTx News
Zephyr Sleep Technologies Inc. (Zephyr) is partnering with Sleep Architects, Inc. (SleepArchiTx) to expand SleepArchiTxu2019s suite of services to include MATRx plus Treatment Planning.
Zephyr Sleep Technologies partnered with SleepArchiTx to integrate MATRx plus Treatment Planning into SleepArchiTx's services, aiming to provide a comprehensive solution for dental practices treating sleep breathing disorders.
2021-01
Sleep Review
Zephyr Sleep Technologies Inc MATRx Plus
The FDA granted a De Novo request for Zephyr Sleep Technologies Inc's MATRx plus, an at-home Class II medical device designed to identify obstructive sleep apnea patients suitable for oral appliance therapy.
2018-09
Journal of Clinical Sleep Medicine
In-home mandibular repositioning during sleep using MATRx plus predicts outcome and efficacious positioning for oral appliance treatment of obstructive sleep apnea
This study, funded by Alberta Innovates and Zephyr Sleep Technologies, investigated the MATRx plus system's ability to predict outcomes and optimal mandibular positioning for oral appliance therapy in obstructive sleep apnea patients.
2022-03
Parsers VC
Zephyr Sleep Technologies u2013 Funding, Valuation, Investors, News
Zephyr Sleep Technologies, a developer of FDA-approved medical devices for sleep-disordered breathing, focuses on improving patient experience and empowering dental teams with its MATRx plus system.
unknown
PitchBook
Zephyr Sleep Technologies 2026 Company Profile - PitchBook
Zephyr Sleep Technologies, founded in 2003, is a medical technology company that has raised $13M in funding over two rounds.
2026-05

Frequently Asked Questions

Zephyr Sleep Technologies' primary product was the MATRx plus, an FDA-cleared, at-home Class II medical device. It was designed to perform both a standard home sleep test (HST) and an oral appliance trial, aiding in the diagnosis and treatment planning for mild to moderate OSA.
The MATRx plus system incorporated proprietary algorithms, artificial intelligence, and machine learning to determine if a patient could be effectively treated with an oral appliance and to identify the optimal therapeutic mandibular position. This technology aimed to reduce treatment failure rates and streamline the oral appliance configuration process.
Home sleep testing was a core component of the MATRx plus, allowing patients to conduct a self-administered sleep test in their own homes. The device recorded data such as nasal airflow, snoring, blood oxygen saturation, pulse, respiratory effort, and body position, which was then uploaded via cloud connectivity for healthcare professionals to review.
The MATRx plus was unique in its ability to predict if a patient would respond to oral appliance therapy and to identify the precise mandibular protrusion required for effective treatment. This helped medical professionals confidently prescribe oral appliances, aiming to improve success rates and reduce the guesswork often associated with this treatment modality.
Before ceasing operations, Zephyr Sleep Technologies had established significant partnerships, notably with Dentsply Sirona for market distribution in the United States, and later with ProSomnus Sleep Technologies and SleepArchiTx for co-marketing and integrated solutions. However, the company ultimately ceased operations on June 25, 2021, due to the material impact of the COVID-19 pandemic and unsuccessful efforts to raise additional equity capital.
Following Zephyr Sleep Technologies' cessation of operations in June 2021, users of the MATRx system were left without a method for predicting optimal oral appliance treatment positions. Other companies, like Sleep Group Solutions, offered trade-in programs for MATRx users to transition to alternative airway measurement systems.

Related Companies

Clarista is a healthcare AI company that focuses on building a “trust layer” for enterprise AI, particularly within regulated industries like healthcare and financial services. The company’s platform aims to address the challenges of data fragmentation, governance, and compliance that often hinder the successful implementation of AI projects in large organizations. Clarista’s technology unifies structured […]

HelloBooks.ai is an AI-powered accounting software company that aims to automate and simplify financial management for small businesses, freelancers, and accounting professionals. The platform utilizes generative AI to handle repetitive bookkeeping tasks such as transaction categorization, receipt capture, bank reconciliation, and report generation. It is designed to reduce manual data entry and improve accuracy, allowing […]

Vero, also known as Vero.ai, is an artificial intelligence company specifically designed to augment clinical workflows and improve patient care within the healthcare sector. Their primary focus is on leveraging AI to streamline administrative tasks, enhance diagnostic accuracy, and personalize treatment plans. By automating routine processes, Vero aims to free up healthcare professionals’ time, allowing […]

Ant Group, a global digital technology provider and operator of Alipay, has significantly expanded its focus into healthcare AI. The company recently upgraded its physician platform, Haodf for Doctor, into ‘AQ for Doctor,’ an AI-powered workstation designed to support physicians across various stages of clinical practice, including online consultations, patient management, clinical decision support, and […]

e4health is a healthcare consulting and services company that provides innovative solutions to hospitals, health systems, outpatient providers, and physician practices. The company focuses on addressing data, quality, and revenue challenges within the healthcare ecosystem. Their services are designed to streamline health information data and workflows, optimize coding, quality, and clinical documentation integrity processes, and […]

PayZen is a healthcare AI company dedicated to solving the healthcare affordability crisis for both patients and providers. The company’s AI-powered platform offers personalized, interest-free, and fee-free patient financing solutions, enabling patients to manage their medical bills through affordable payment plans tailored to their unique ability to pay. This approach aims to increase access to […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.